|
|
|||||||||||
1. Polyarteritis nodosa
(Trust Mark: Doctor-Reviewed)
Polyarteritis nodosa is a serious blood vessel disease in which small and medium-sized arteries become swollen and damaged. Reviewer: Neil J. Gonter, MD, Assistant Professor of Medicine, Columbia University, New York, NY, and private practice specializing in Rheumatology at Rheumatology Associates of North Jersey, Teaneck, NJ. Review provided by Verimed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
2. Pan American Health Organization : PAN AMERICAN HEALTH ORGANIZATION
(Trust Mark: Doctor-Reviewed)
The origin of the Pan American Health Organization (PAHO) dates back to 1902 when the First International Sanitary Convention of the American Republics, meeting in Washington, DC, established the International Sanitary Bureau. The bureau was to pr... Author: GEORGE A. O. ALLEYNE, A. DAVID BRANDLING-BENNETT Expand your search to include all of U.S. News
3. Polyarteritis Nodosa -- AOL Medical Encyclopedia
Many researchers suspect that the disorder is due to disturbances of the body s immune system. Blood vessels in any organ or organ system may be affected, i... http://body.aol.com/conditions/polyarteritis-nodosa
4. Polyarteritis Nodosa -- Information from Healthwise
Polyarteritis nodosa, a rare multisystem disorder that usually becomes apparent between the ages of 40 and 50 years, is characterized by widespread inflammation, weakening, and degeneration of small- and medium-sized arteries. http://www.everettclinic.com/kbase/nord/nord666.htm
5. polyarteritis nodosa -- Information from Harvard Medical School
If polyarteritis nodosa is related to hepatitis B, you may be treated with prednisone to control arterial inflammation and antiviral medications such as interferon (to fight the hepatitis infection). However, most patients with polyarteritis... http://www.intelihealth.com/IH/ihtIH/WSIHW000/9339/24697.html |
advertisement |
Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.